Get 40% Off
🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks.Unlock full list

Asian business confidence gains steam, pandemic still top risk: Thomson Reuters/INSEAD survey

Published 12/22/2020, 10:09 PM
Updated 12/22/2020, 10:36 PM
© Reuters. FILE PHOTO: Vials of AstraZeneca's COVISHIELD, coronavirus disease (COVID-19) vaccine, are seen before they are packaged inside a lab at Serum Institute of India, Pune
TRI
-

By Anshuman Daga

SINGAPORE (Reuters) - Asian firms turned most optimistic in the fourth quarter this year, a Thomson Reuters/INSEAD survey showed, as business activity picked up in the region and COVID-19 vaccines started rolling out in Western countries ahead of their Asian launch.

The outlook for Asian companies in the next six months tracked by the Thomson Reuters/INSEAD Asian Business Sentiment Index jumped to 62 this quarter from 53 in the third quarter.

The latest number according to the survey of 101 firms across 11 Asia-Pacific countries was the highest since the fourth quarter of 2019. A reading above 50 indicates a positive outlook.

"There's a sense of optimism going forward," said Antonio Fatas, Singapore-based economics professor at global business school INSEAD.

"Things are getting better but they are getting better with still a dose of uncertainty. The effect of the crisis is very different across sectors," he added, noting the weakness in the transport sector due to curbs on global travel.

Still, more than half the respondents polled flagged persistent cases of the novel coronavirus as well as the possible scarcity of vaccines in parts of the world - at least initially - as their biggest risk.

While the United States and Britain have already started vaccinating their populations, few Asian countries expect to get significant amounts of coronavirus vaccines in coming weeks.

Some Asian countries are still running their own late-stage trials of vaccines, while others are allowing time to check for any side effects in people inoculated elsewhere.

A quarter of the companies in the survey, which was conducted between Dec. 4-18, were most concerned about businesses cutting jobs, which would hurt consumption.

Yet others flagged as their top risks a withdrawal of stimulus by central banks, and newly elected United States President Joe Biden keeping a tough line on China.

The coronavirus pandemic has brought on the worst global economic slowdown since the Great Depression, with millions of jobs lost and industries brought to their knees.

Still, Asia, which has had greater success in controlling the virus than Europe and the United States, is leading hopes of an economic recovery.

Graphic: Business sentiment in Asia vs share performance https://fingfx.thomsonreuters.com/gfx/mkt/rlgpdqxddvo/Business%20sentiment%20in%20Asia%20vs%20share%20performance.jpg

YEAR OF THE PHOENIX

"After a year marked by economic contraction, 2021 stands to be the 'year of the phoenix', with a strong rebound in global gross domestic product and corporate earnings in 2021 thanks to the unrolling of vaccines and substantial policy support," said Cesar Perez Ruiz, chief investment officer at Pictet Wealth Management.

A recovery to pre-pandemic levels in China, the world's second-largest economy, has fuelled revival hopes. Equity markets in China, South Korea and Taiwan are up at least 20% this year, leading the region's gains.

According to the Thomson Reuters (NYSE:TRI) INSEAD survey, some 44% of the companies polled in the fourth quarter were positive about their outlook for the next six months, up sharply from 28% in the third quarter and nearly 8% in the second.

About 58% of the firms said they did not hire or lay off people this quarter, and a fifth said staffing levels were lower. This was similar to numbers in the third quarter. In the second quarter, 62% of the companies said they had cut jobs.

"While I still see some uncertainty, the numbers are good," said Fatas. "It looks like a recovery that is taking speed and where more businesses feel confident."

Companies polled included India's Housing Development Finance Corp Ltd, Japanese car maker Suzuki Motor Corp, and Thai electronics company Delta Electronics (Thailand) PCL.

© Reuters. FILE PHOTO: Vials of AstraZeneca's COVISHIELD, coronavirus disease (COVID-19) vaccine, are seen before they are packaged inside a lab at Serum Institute of India, Pune

Note: Companies surveyed can change from quarter to quarter.

 

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.